
    
      To investigate if administration of 3 weeks og GH (10-30 microgram/kg/day) and subsequent
      Pegvisomant (10-15 mg/day) influence serum concentrations of the inflammatory variables Tumor
      Necrosis Factor α (TNF-α), Interleukin-6 (IL-6), high sensitive CRP (hsCRP) and the newly
      discovered acute phase protein YKL-40. The study involves 12 healthy volunteers age from
      22-65 years.
    
  